By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo

TheMediTary.Com

Medical Information, Documents, News - TheMediTary.Com

  • Home
  • News
  • Drugs
  • Drugs A-Z
  • Medical Answers
  • About Us
  • Contact
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo
Search Drugs
  • Drugs
    • Latest Drugs
    • Drugs A-Z
    • Medical Answers
  • News
    • FDA Alerts
    • Medical News
    • Health
    • Consumer Updates
    • Children's Health
  • More TheMediTary.Com
    • About Us
    • Contact
Follow US
Home > Drugs > Treatments > Diffuse Large B-Cell Lymphoma

Medications for Diffuse Large B-Cell Lymphoma

Other names: DLBCL

Diffuse Large B-Cell Lymphoma (DLBCL) is the most common subtype of non-Hodgkin's lymphoma. Lymphoma is a cancer of the lymphatic system which occurs when a developing white cell (lymphocyte) goes through an abnormal change, multiplies and accumulates in various parts of the body.

DLBCL is a fast growing lymphoma that develops from the mature B cells and can arise in the lymph nodes or in other organs or tissues. Some of the rarer DLBCL have their own classification but the most common subtype is known as 'not otherwise specified'.

General symptoms of DLBCL are fevers, night sweats and weight loss. Another symptom is painless and fast growing lymph nodes, these swelling can also occur in the abdomen, liver, lungs, skin and other areas of the body.

Drugs used to treat Diffuse Large B-Cell Lymphoma

Name Drug Class Updated
Tisagenlecleucel Miscellaneous antineoplastics 16-Aug-2023
Lisocabtagene maraleucel Miscellaneous antineoplastics 14-Aug-2023
Loncastuximab tesirine Miscellaneous antineoplastics 13-Aug-2023
Loncastuximab (monograph) Drugs 13-Aug-2023
Hyaluronidase and rituximab CD20 monoclonal antibodies 13-Aug-2023
Tafasitamab CD19 monoclonal antibodies 12-Aug-2023
Selinexor Miscellaneous antineoplastics 12-Aug-2023
Rituximab Antirheumatics 12-Aug-2023
Polatuzumab vedotin Miscellaneous antineoplastics 11-Aug-2023
Zynlonta Miscellaneous antineoplastics 14-Jul-2023
Ruxience CD20 monoclonal antibodies 14-Jul-2023
Riabni CD20 monoclonal antibodies 14-Jul-2023
Polivy Miscellaneous antineoplastics 13-Jul-2023
Glofitamab (monograph) Drugs 23-Aug-2023
Monjuvi CD19 monoclonal antibodies 13-Jul-2023
Epkinly CD20 monoclonal antibodies 13-Jul-2023
Columvi Drugs 13-Jul-2023
Yescarta Miscellaneous antineoplastics 12-Jul-2023
Xpovio Miscellaneous antineoplastics 12-Jul-2023
Truxima CD20 monoclonal antibodies 12-Jul-2023
Rituxan hycela CD20 monoclonal antibodies 11-Jul-2023
Rituxan Antirheumatics 11-Jul-2023
Breyanzi Miscellaneous antineoplastics 10-Jul-2023
Kymriah Miscellaneous antineoplastics 05-Sep-2023
Share this Article
Latest News
Medical News

Obesity, unhealthy lifestyles may cause heart to age by 5–45 years

May 08, 2025
Aging: As little as 5 minutes of exercise may keep the brain healthy
Prostate cancer: Simple urine test may help with early detection
Cancer treatment side effects: Exercise may reduce pain, fatigue
Alzheimer's: Exercising in middle age may reduce beta-amyloid in brain...
Heart disease: Just 3 minutes of 'incidental activity' may lower...
Related Drugs
Fidanacogene Elaparvovec
Cerave Anti-Itch
Centrum Adult
Crovalimab
Cyltezo Prefilled Syringe
Zepbound Pen
Mylanta One
Uretron Ds
Medihoney Wound And Burn Dressing
Lidotrode

Categories

  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health

About US

Welcome to TheMediTary.Com

Our website provides reliable and up-to-date information on various medical topics. We empower individuals to take charge of their health by simplifying complex medical jargon and providing practical tips and advice. We prioritize the privacy and confidentiality of our users and welcome feedback to improve our services.

Website use data of FDA and other sources

DMCA.com Protection Status Truste Protection Status Trust Mark Protection Status
HONcode logo We comply with the HONcode standard for trustworthy health information.
Quick Link
  • About Us
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Accessibility Policy
  • Terms & Conditions
  • Disclaimer
  • DMCA
  • Do Not Sell My Personal Information
  • Sitemap
  • Care Notes
  • Health Guide
  • Professional
Drugs
  • New Drugs
  • Medical Answers
  • Drugs A-Z
  • Drug Classes
  • Drug Dosage
  • Pill Identifier
  • Consumer Infor
  • Side Effects
  • Inactive Ingredients
  • Pregnancy Warnings
  • Patient Tips
  • Treatments
News
  • Latest News
  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health
Find US
  • Medium
  • Google Site
  • Blogspot
  • API
  • Reddit
  • Tumblr
  • Scoop.it
  • Substack
  • Wordpress
  • Wix
  • Behance

© 2025 TheMediTary.Com All rights reserved. Operated by